Zimbabwe has turned down a significant US health deal worth 367 million US dollars (272 million pounds) spanning five years because of the United States' demand for sensitive biological samples.
The decision was revealed after a government memo from December was disclosed, revealing that President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesman has since clarified that the United States was seeking health data for research and commercial purposes but refused to share the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more dialogue to find a deal suitable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a court suspended a similar deal with the US after concerns were raised about the safety of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral agreements to boost transparency and responsibility.
As per statements, 16 nations in Africa have so far signed these new health pacts, representing more than $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million currently on HIV treatment via US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," his statement read.
"Effectively, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our population should a new health crisis emerge."
National Interest and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures previously established through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This framework is intended to ensure that when a nation provides its data, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how future collaboration might be arranged in a way that honours the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but suggested that talks need to persist since much of the nation's HIV programmes depended on international support.
"In cases where specific concerns arise, such as those relating to data governance or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," the group commented.
This impasse emphasises the continuing debate between accepting much-needed international aid and safeguarding local interests in an ever more interconnected world.